298 related articles for article (PubMed ID: 29701021)
41. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.
Liu B; Saber A; Haisma HJ
Drug Discov Today; 2019 Apr; 24(4):955-970. PubMed ID: 30849442
[TBL] [Abstract][Full Text] [Related]
42. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
[TBL] [Abstract][Full Text] [Related]
43. CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.
Franco-Tormo MJ; Salas-Crisostomo M; Rocha NB; Budde H; Machado S; Murillo-Rodríguez E
J Mol Neurosci; 2018 May; 65(1):10-16. PubMed ID: 29732484
[TBL] [Abstract][Full Text] [Related]
44. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
Yang F; Li Y
Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
[TBL] [Abstract][Full Text] [Related]
45. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
46. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
47. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
Du QS; Cui J; Zhang CJ; He K
J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
[TBL] [Abstract][Full Text] [Related]
48. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
Hu X; Meng X; Liu Q; Li J; Wang K
Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
[TBL] [Abstract][Full Text] [Related]
49. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
50. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
51. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
52. DNA fragment editing of genomes by CRISPR/Cas9.
Li JH; Shou J; Wu Q
Yi Chuan; 2015 Oct; 37(10):992-1002. PubMed ID: 26496751
[TBL] [Abstract][Full Text] [Related]
53. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
54. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
55. [The application of CRISPR/Cas9 genome editing technology in cancer research].
Wang DY; Ma N; Hui Y; Gao X
Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
[TBL] [Abstract][Full Text] [Related]
56. Genome editing in Streptococcus mutans through self-targeting CRISPR arrays.
Gong T; Tang B; Zhou X; Zeng J; Lu M; Guo X; Peng X; Lei L; Gong B; Li Y
Mol Oral Microbiol; 2018 Dec; 33(6):440-449. PubMed ID: 30329221
[TBL] [Abstract][Full Text] [Related]
57. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
58. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
59. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
Chakraborty C; Teoh SL; Das S
Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
[TBL] [Abstract][Full Text] [Related]
60. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
